Jan 17, 2023 / 01:30PM GMT
Operator
Good morning, and welcome to ShockWave's Conference Call. (Operator Instructions) As a reminder, this call is being recorded for replay purposes.
I'd now like to turn the call over to Debbie Kaster, Vice President of Investor Relations at ShockWave, for a few introductory comments.
Debbie Kaster - ShockWave Medical, Inc. - VP of IR
Thank you all for participating in today's call. Joining me today from ShockWave Medical are Doug Godshall, President and Chief Executive Officer; and Dan Puckett, Chief Financial Officer. Also joining us is Dr. Gregg Stone, Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine and Population Health Sciences and Policy and Principal Investigator on Neovasc COSIRA-II trial.
Earlier today, ShockWave announced, it has entered into a definitive agreement to acquire Neovasc. The company focused on the minimally invasive treatment of refractory angina. Additionally, ShockWave announced its preliminary fourth quarter and full year 2022 revenues as well as full year 2023 revenue
Shockwave Medical Investor Call to Discuss Acquisition of Neovasc Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers